NCT04986657View on ClinicalTrials.gov

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

NARecruitingINTERVENTIONAL
Enrollment

325

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Whole Genome SequencingAcute Myeloid LeukemiaMyelodysplastic Syndromes
Interventions
DEVICE

ChromoSeq

Novel, streamlined whole genome sequencing approach

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER